Concepedia

Christel Vangestel

CV

28

Publications

814

Citations

17

H-Index

2008

Active since

Affiliations

University of Antwerp(Current)

Antwerp University Hospital

Ghent University Hospital

Molecular Targeting Technologies (United States)

University of Groningen

Christel Vangestel is an author at University of Antwerp specializing in medicine, oncology, and pharmacology.

ORCID

Top concepts

Publications per year

2008–2023

28

Publications

28

Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA5m chelators

Euy Sung Moon, Filipe Elvas, Gwendolyn Vliegen et al. · EJNMMI Radiopharmacy and Chemistry · 2020 · 107 citations · Full text

Long-term acquired everolimus resistance in pancreatic neuroendocrine tumours can be overcome with novel PI3K-AKT-mTOR inhibitors

Timon Vandamme, Matthias Beyens, Ken Op de Beeck et al. · British Journal of Cancer · 2016 · 73 citations · Full text

ATG4B inhibitors with a benzotropolone core structure block autophagy and augment efficiency of chemotherapy in mice

Ammar Kurdi, Matthias Cleenewerck, Christel Vangestel et al. · Biochemical Pharmacology · 2017 · 69 citations

, , +10

Characterization of [99mTc]Duramycin as a SPECT Imaging Agent for Early Assessment of Tumor Apoptosis

Filipe Elvas, Christel Vangestel, Sara Rapic et al. · Molecular Imaging and Biology · 2015 · 51 citations · Full text

<sup>99m</sup>Tc-Duramycin SPECT Imaging of Early Tumor Response to Targeted Therapy: A Comparison with<sup>18</sup>F-FDG PET

Filipe Elvas, Jan Boddaert, Christel Vangestel et al. · Journal of Nuclear Medicine · 2016 · 49 citations · Full text

Rows per page

1–5 of 28